Cleared Traditional

K101026 - POWERED PD-IO INFUSION SYSTEM, EZ-IO HUMERAL HEAD, POWERED PH-IO

K101026 is an FDA 510(k) clearance for POWERED PD-IO INFUSION SYSTEM, manufactured by Vidacare Corporation. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K101026 · Vidacare Corporation · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2010
Decision
105d
Days
Class 2
Risk

K101026 is an FDA 510(k) clearance for the POWERED PD-IO INFUSION SYSTEM, EZ-IO HUMERAL HEAD, POWERED PH-IO. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Vidacare Corporation (Irvine, US). The FDA issued a Cleared decision on July 27, 2010 after a review of 105 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Vidacare Corporation devices

FDA 510(k) Submission Details - K101026

510(k) Number K101026 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 13, 2010
Decision Date July 27, 2010
Days to Decision 105 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 129d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 500
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K101026.
VACUETTE QUICKSHIELD WITH SNAPPY TUDE HOLDER
K102774 · Greiner Bio-One North America, Inc. · Oct 2010
FASTX STERNAL INTRAOSSEOUS DEVICE
K100124 · Pyng Medical Corp. · Aug 2010
ZIRCONIA SYRINGE NEEDLE
K093043 · Kuo Tai Hospital Managements & Consultant Co., Ltd. · Aug 2010
NOVOTWIST NEEDLE, MODELS 30G * 8MM (1/3) 32 G TIP * 5 MM(1/5')
K093109 · Novo Nordisk, Inc. · Jun 2010
ULTICARE DISPOSABLE PEN NEEDLES
K100812 · Ultimed, Inc. · Jun 2010
CLICKFINE PEN NEEDLE
K100436 · Ypsomed AG · Apr 2010